BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, January 13, 2026
Home
»
Newsletters
» BioWorld
BioWorld
July 16, 2010
View Archived Issues
A Two-Step Procedure Leads To A One-For-All Flu Vaccine
Read More
Still No Partner; Somaxon Adds Sales Team for Silenor Launch
Read More
Evotec Acquiring DeveloGen for €16M Cash, Shares, Earnouts
Read More
Clinuvel's Former Tan Drug Succeeds in Porphyria Trial
Read More
Clinic Roundup
Read More
Stock Movers
Read More
Other News To Note
Read More
FDA Panel Rejects Vivus Obesity Pill Qnexa
GAITHERSBURG, Md. – An FDA panel Thursday said the risks of fetal exposure, increased heart rate, depression and other problems outweighed the benefits of weight loss for Vivus Inc.'s Qnexa (phentermine/topiramate). (BioWorld Today)
Read More
Tissue-Bone Firm BioMimetic Raising $40M in Stock Offering
Read More
